The Impact of Temporary Ovarian Ischemia due to Uterine Turnicate application at the time of Myomectomy
Phase 1
- Conditions
- Myomectomy.Acute inflammatory disease of uterus
- Registration Number
- IRCT2016050723666N2
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 32
Inclusion Criteria
Lack of infertility in patients with ovarian factor, No Poly Cystic Ovary, No endometriosis, Body Mass Index <30, Regular menstrual pattern, An informed consent for inclusion
Exclusion criteria: No informed consent for inclusion, Patients that their physician determines that treatment could be associated with risk.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anti Mullerian Hormone. Timepoint: Before and 3 months after surgery. Method of measurement: Bleeding sample.
- Secondary Outcome Measures
Name Time Method